Understanding Biosimilar Insulin & the Role of Rapid Acting Insulin in Intensification

Introduction

Take This Event

In this lecture, Dr. Ahmed will outline basal insulin therapy for T2D patients highlighting on biosimilars while also discussing the differences between Premixes and Basal-Bolus in terms of flexibility and simplicity.

Objectives

1. Understanding why postprandial matters and why it's important to tackle postprandial hyperglycemia.
2. Distinguish insulin profile for premix insulin options and describe patient
characteristics, lifestyle options and patient capabilities suitable for each premixed insulin
options.
3. Understand the differences between Premixes and Basal-Bolus when is comes flexibility and simplicity.

See Registration Policies, Cancellations & Refunds